Tempus AI (NASDAQ:TEM) Trading Down 1.3% – Should You Sell?

Tempus AI, Inc. (NASDAQ:TEM) shares were down 1.3% on Wednesday . The company traded as low as $55.30 and last traded at $57.78. Approximately 3,867,270 shares changed hands during trading, a decline of 25% from the average daily volume of 5,141,932 shares. The stock had previously closed at $58.57.

Analyst Ratings Changes

Several brokerages recently weighed in on TEM. TD Cowen reaffirmed a “buy” rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Guggenheim reiterated a “buy” rating on shares of Tempus AI in a research report on Tuesday, February 25th. William Blair reissued a “market perform” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Loop Capital dropped their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday, January 14th. Finally, Wolfe Research lowered Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Price Performance

The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm has a 50 day moving average price of $57.42 and a 200-day moving average price of $51.46.

Insider Activity at Tempus AI

In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of the company’s stock in a transaction on Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the transaction, the chief accounting officer now owns 57,237 shares of the company’s stock, valued at $3,434,220. This represents a 19.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Eric P. Lefkofsky sold 476,209 shares of the firm’s stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $49.84, for a total transaction of $23,734,256.56. Following the completion of the transaction, the chief executive officer now directly owns 6,502,643 shares in the company, valued at $324,091,727.12. This represents a 6.82 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,598,969 shares of company stock worth $317,194,162.

Institutional Trading of Tempus AI

A number of hedge funds have recently added to or reduced their stakes in TEM. Operose Advisors LLC purchased a new position in Tempus AI in the fourth quarter valued at about $25,000. First Horizon Advisors Inc. purchased a new position in Tempus AI during the 3rd quarter worth approximately $30,000. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI during the fourth quarter worth $34,000. Prestige Wealth Management Group LLC raised its stake in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after buying an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC acquired a new position in Tempus AI in the fourth quarter valued at approximately $49,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.